Michael Gelband’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-84,558
Closed -$1.74M 1961
2026
Q1
$1.74M Buy
84,558
+43,558
+106% +$982K 0.01% 835
2025
Q4
$972K Buy
41,000
+20,218
+97% +$492K 0.01% 1006
2025
Q3
$517K Buy
+20,782
New +$447K 0.01% 1173
2025
Q1
Sell
-15,181
Closed -$297K 1894
2024
Q4
$297K Sell
15,181
-102,397
-87% -$2.03M ﹤0.01% 1283
2024
Q3
$2.14M Buy
117,578
+48,737
+71% +$930K 0.01% 709
2024
Q2
$1.2M Buy
68,841
+55,237
+406% +$979K 0.01% 957
2024
Q1
$267K Sell
13,604
-40,278
-75% -$851K ﹤0.01% 1290
2023
Q4
$1.24M Sell
53,882
-173,329
-76% -$3.88M 0.01% 736
2023
Q3
$5.23M Buy
227,211
+160,978
+243% +$4.09M 0.05% 364
2023
Q2
$1.73M Sell
66,233
-140,726
-68% -$3.72M 0.01% 870
2023
Q1
$5.71M Buy
206,959
+70,532
+52% +$1.86M 0.05% 469
2022
Q4
$3.1M Buy
136,427
+71,069
+109% +$1.98M 0.05% 492
2022
Q3
$2.23M Buy
65,358
+46,617
+249% +$1.72M 0.03% 758
2022
Q2
$546K Buy
+18,741
New +$476K 0.01% 1314
2021
Q4
Sell
-31,929
Closed -$752K 2512
2021
Q3
$752K Buy
+31,929
New +$1.11M 0.01% 1166

Other funds holding PRVA

Michael Gelband's PRVA Position: Q2 2026 in Review

Michael Gelband sold out of Privia Health (PRVA) in Q2 2026, closing a stake of 84,558 shares — an estimated $1.74M sold.

Michael Gelband first reported a position in PRVA in Q3 2021 and held it in 15 quarters. The position peaked at $5.71M in Q1 2023. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Michael Gelband reported no remaining Privia Health position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 84,558 Privia Health shares in Q2 2026, an estimated $1.74M.
  • Michael Gelband first reported a position in Privia Health in Q3 2021 and held it in 15 quarters.
  • Michael Gelband's Privia Health position peaked at $5.71M in Q1 2023.
  • 300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.